PLNT:NYSEPlanet Fitness, Inc. Analysis
Data as of 2026-06-14 - not real-time
$51.01
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Planet Fitness is trading at $51.01, well below its 200‑day SMA of $87.42 and with a 30‑day volatility of 115%, indicating a steep bearish technical backdrop. Revenue growth remains robust at 19.7% YoY and margins are healthy (gross 58.8%, operating 32.5%, profit 17.8%), yet the balance sheet is strained: total debt of $2.94 B dwarfs cash of $0.47 B and book value per share is negative ($‑6.09), flagging equity erosion. DCF analysis places fair value near $29.40, suggesting the stock is significantly overvalued relative to intrinsic estimates.
Compounding the financial stress, recent headlines detail a **potential securities‑fraud investigation** tied to a 31% share‑price plunge and weaker-than‑expected FY 2026 outlook, while volume trends are decreasing. Although Q1 2026 showed a 21.9% sales increase and a modest CEO share purchase, the confluence of high volatility, regulatory scrutiny, and overvaluation outweighs the short‑term upside, urging caution.
Compounding the financial stress, recent headlines detail a **potential securities‑fraud investigation** tied to a 31% share‑price plunge and weaker-than‑expected FY 2026 outlook, while volume trends are decreasing. Although Q1 2026 showed a 21.9% sales increase and a modest CEO share purchase, the confluence of high volatility, regulatory scrutiny, and overvaluation outweighs the short‑term upside, urging caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Pending securities‑fraud investigation
- Bearish technical indicators (price below all SMAs, RSI 39)
- Significant overvaluation vs DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong revenue growth and operating margins
- High debt load and negative equity
- Volatility and decreasing volume
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for franchise expansion and margin stability
- Regulatory outcome uncertainty
- Valuation gap may narrow if fundamentals improve
Key Metrics & Analysis
Financial Health
Revenue Growth19.70%
Profit Margin17.77%
P/E Ratio18.4
ROA8.37%
P/B Ratio-8.4
Op. Cash Flow$432.0M
Free Cash Flow$161.7M
Technical Analysis
TrendBearish
RSI39.0
Support$49.16
Resistance$55.03
MA 20$51.83
MA 50$59.95
MA 200$87.42
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$29.41
Target Price$66.64
Upside/Downside30.64%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.48
Volatility115.23%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.